CMO Moves: Regulatory catalysts for drug manufacturing-April
Pharmaceutical Technology
JULY 14, 2022
In this ongoing series , we put a spotlight on contracts between pharma companies and contract manufacturing organizations (CMOs). In 2021, the US FDA had decreed that about 60 million doses of the vaccine made at Emergent’s factory be discarded after a batch was contaminated. .
Let's personalize your content